# BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

Study · id `cardio:ct-nct06722196` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06722196](<https://clinicaltrials.gov/study/NCT06722196>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06722196

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT06722196. Randomized; quadruple masking; primary purpose prevention. Start 2025-02-15 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT06722196, source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)
- Started: 2025-02-15 (actual) (ClinicalTrials.gov record NCT06722196, source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)
- Primary completion: 2027-01-15 (anticipated) (ClinicalTrials.gov record NCT06722196, source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)
- Completion: 2027-12-15 (anticipated) (ClinicalTrials.gov record NCT06722196, source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06722196, source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06722196-2025-12-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
- Acronym: BEAT-AF
- Condition: Atrial Fibrillation (AF)
- Intervention (Drug): topical amiodarone
- Intervention (Other): saline solution patch
- Lead sponsor: Jilin Heart Hospital
- Lead sponsor class: OTHER
- Collaborator: Cornell University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as a collaborator: Cornell University (`cardio:org-cornell-university`)

## Provenance

Content hash: 5ce5337842d8299e6d25f7426dcc3d55def690fec1b64f0179d010c03c6364ae
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
